Acatvis completes acquisition of Turkish company Skip to content

Acatvis completes acquisition of Turkish company

The generic drug maker Acatvis has purchased a 11% stake in the Turkish generics producer Fako for USD 20.4 million according to Icelandic Broadcasting System, RÚV. It now owns 100% of Fako.

Fako is the 5th largest generics company in Turkey and makes and sells generic drugs and supplies for drug manufacturing. It employs 1.200 people and is headquartered in Instanbul.

Share article

Facebook
Twitter

Recommended Posts